Increased serum FABP4 levels were closely associated with blunted insulin sensitivity, increased insulin secretion, and elevated fasting and postchallenge glucagon levels in patients with T2D, which implied that excessive expression of FABP4 may get involved in the pancreatic islet β-cell and α-cell dysfunctions. Here, INS is linked to type 2 diabetes mellitus.